| |
| |
|
| Insider
Information: |
Soland Daniel B |
| Relationship: |
Director |
| City: |
Emeryville |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
136,845 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$619,314 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
136,845 |
|
|
| Total
Value |
$619,314 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-3.0
|
0.0
|
| Percentage
Gain/Loss : |
 -67.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Viropharma Inc |
VPHM |
VP, Chief Operating Of... |
2014-01-24 |
0 |
2007-08-16 |
0 |
Premium* |
|
|
Acadia Pharmaceuticals Inc |
ACAD |
Director |
2023-06-01 |
28,002 |
2018-03-01 |
0 |
Premium* |
|
|
Kalvista Pharmaceuticals Inc |
KALV |
Director |
2019-09-27 |
10,000 |
2019-09-26 |
0 |
Premium* |
|
|
Aceragen, Inc |
ACGN |
|
2021-06-18 |
78,843 |
|
0 |
Premium* |
|
|
DBV Technologies SA |
DBVT |
Director |
2023-08-01 |
20,000 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DBVT |
DBV Technologies SA |
Director |
– • – |
2023-08-01 |
4 |
B |
$1.62 |
$24,300 |
D/D |
15,000 |
20,000 |
2.39 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
Director |
– • – |
2023-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,552 |
28,002 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
Director |
– • – |
2022-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,391 |
19,450 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
Director |
– • – |
2021-06-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,059 |
13,059 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
CHIEF OPERATING OFFICER |
• – – |
2021-06-18 |
4 |
B |
$1.19 |
$59,500 |
D/D |
50,000 |
78,843 |
0.01 |
% |
|
| ACGN |
Aceragen, Inc |
CHIEF OPERATING OFFICER |
• – – |
2021-03-05 |
4 |
B |
$3.90 |
$38,950 |
D/D |
10,000 |
28,843 |
0.01 |
% |
|
| ACGN |
Aceragen, Inc |
Chief Operating OfficerOfficer |
• – – |
2021-01-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,843 |
|
% |
|
| DBVT |
DBV Technologies SA |
Director |
– • – |
2021-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Director |
– • – |
2019-09-27 |
4 |
B |
$11.87 |
$94,498 |
D/D |
7,962 |
10,000 |
2.39 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Director |
– • – |
2019-09-26 |
4 |
B |
$11.90 |
$24,252 |
D/D |
2,038 |
2,038 |
2.39 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
|
– • – |
2018-03-02 |
4 |
B |
$22.52 |
$67,560 |
D/D |
3,000 |
10,000 |
0.01 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
|
– • – |
2018-03-01 |
4 |
B |
$23.02 |
$167,350 |
D/D |
7,000 |
7,000 |
0.01 |
- |
|
| VPHM |
Viropharma Inc |
VP, Chief Operating Officer |
• • – |
2014-01-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(65,818) |
0 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP, Chief Operating Officer |
• • – |
2014-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
65,818 |
65,818 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP, Chief Operating Officer |
• • – |
2014-01-24 |
4 |
D |
$50.00 |
$7,666,600 |
D/D |
(153,332) |
0 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP, Chief Operating Officer |
• • – |
2014-01-08 |
4 |
D |
$49.80 |
$214,489 |
D/D |
(4,307) |
153,332 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP, Chief Operating Officer |
• • – |
2014-01-08 |
4 |
OE |
$5.91 |
$182,222 |
D/D |
19,289 |
153,890 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP, Chief Operating Officer |
• • – |
2013-12-27 |
4 |
D |
$49.86 |
$90,197 |
D/D |
(1,809) |
138,350 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP, Chief Operating Officer |
• • – |
2013-12-27 |
4 |
OE |
$5.91 |
$67,965 |
D/D |
11,500 |
140,159 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP, Chief Operating Officer |
• • – |
2013-12-18 |
4 |
D |
$49.74 |
$3,187,488 |
D/D |
(64,083) |
128,659 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP, Chief Operating Officer |
• • – |
2013-12-18 |
4 |
OE |
$5.91 |
$959,521 |
D/D |
120,784 |
175,213 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP, Chief Operating Officer |
• – – |
2012-03-01 |
4 |
S |
$32.99 |
$989,700 |
D/D |
(30,000) |
42,881 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP, Chief Operating Officer |
• – – |
2010-05-07 |
4 |
B |
$11.91 |
$119,100 |
D/D |
10,000 |
93,638 |
2.74 |
- |
|
| VPHM |
Viropharma Inc |
VP, Chief Operating Officer |
• – – |
2010-05-06 |
4 |
B |
$12.52 |
$125,203 |
D/D |
10,000 |
83,638 |
2.74 |
- |
|
| VPHM |
Viropharma Inc |
VP, Chief Operating Officer |
• – – |
2009-03-12 |
4 |
B |
$4.05 |
$121,500 |
D/D |
30,000 |
70,000 |
2.74 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
